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Differential Effects of Glucocorticoid and Antiglucocorticoid Treatment
on Ovarian Progesterone and Relaxin Secretion in the Pig
Abstract
Pregnancy lasts about 114 days in pigs. Porcine corpora lutea on the ovaries produce not only progesterone
but also relaxin (RLX), a peptide hormone that plays a critical role in suppressing uterine motility during
pregnancy and in remodeling connective tissues in preparation for imminent parturition. Progesterone
concentrations in peripheral blood remain elevated (_25 ng ml -1 ) for the major part of pregnancy and
decrease just before parturition. The decrease in progesterone coincides with peak prepartum RLX release.
Glucocorticoid or antiglucocorticoid steroid, RU 486, administration during late pregnancy can induce
parturition in the pig. Peak release of RLX and a coincident decrease of progesterone in the circulating blood
also can occur in the complete absence of fetuses and uterus (hysterectomy) in the pig. The effects of
glucocorticoid or antiglucocortico-steroid administration to such hysterectomized pigs on the secretion of
RLX and progesterone were examined in this experiment. Unmated Yorkshire gilts were hysterectomized on
days 6–8 (estrus = day 0) and given a glucocorticoid, dexamethasone, from days 110–118; control animals
received vehicle injection during this period. The RU 486 was orally administered once daily (days 111–115)
at 0800 hours; placebo-treated controls were given the same amount of feed without the drug at this time. The
RLX concentrations in blood were markedly suppressed (P<.01) during dexamethasone treatment, whereas a
peak release of RLX occurred in the control group on day 113. In contrast, progesterone concentrations were
unaffected by dexamethasone treatment compared with the controls. Upon withdrawal of dexamethasone on
day 118, RLX concentrations began to increase and peaked at (P<.01) on day 120. In contrast, the
antiglucocorticosteroid caused a marked elevation in circulating levels of progesterone and delayed RLX
release until after the end of drug treatment on day 115. Results indicate that a synthetic glucocorticoid,
dexamethasone, suppresses RLX secretion without causing luteolysis and such suppression is reversible;
progesterone secretion remained unaffected. In contrast, the antiglucocorticoid RU 486 raised progesterone
plasma concentration and delayed RLX peak release but did not suppress it during treatment. This experiment
provides further evidence that relaxin and progesterone secretion from aging corpora lutea of pigs are
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Summary and Implications
Pregnancy lasts about 114 days in pigs. Porcine corpora
lutea on the ovaries produce not only progesterone but also
relaxin (RLX), a peptide hormone that plays a critical role in
suppressing uterine motility during pregnancy and in
remodeling connective tissues in preparation for imminent
parturition. Progesterone concentrations in peripheral blood
remain elevated (_25 ng ml-1) for the major part of
pregnancy and decrease just before parturition. The decrease
in progesterone coincides with peak prepartum RLX release.
Glucocorticoid or antiglucocorticoid steroid, RU 486,
administration during late pregnancy can induce parturition
in the pig. Peak release of RLX and a coincident decrease of
progesterone in the circulating blood also can occur in the
complete absence of fetuses and uterus (hysterectomy) in
the pig.
The effects of glucocorticoid or antiglucocortico-steroid
administration to such hysterectomized pigs on the secretion
of RLX and progesterone were examined in this experiment.
Unmated Yorkshire gilts were hysterectomized on days 6Ð8
(estrus = day 0) and given a glucocorticoid, dexamethasone,
from days 110Ð118; control animals received vehicle
injection during this period. The RU 486 was orally
administered once daily (days 111Ð115) at 0800 hours;
placebo-treated controls were given the same amount of
feed without the drug at this time. The RLX concentrations
in blood were markedly suppressed (P<.01) during
dexamethasone treatment, whereas a peak release of RLX
occurred in the control group on day 113. In contrast,
progesterone concentrations were unaffected by
dexamethasone treatment compared with the controls. Upon
withdrawal of dexamethasone on day 118, RLX
concentrations began to increase and peaked at (P<.01) on
day 120. In contrast, the antiglucocorticosteroid caused a
marked elevation in circulating levels of progesterone and
delayed RLX release until after the end of drug treatment on
day 115. Results indicate that a synthetic glucocorticoid,
dexamethasone, suppresses RLX secretion without causing
luteolysis and such suppression is reversible; progesterone
secretion remained unaffected. In contrast, the
antiglucocorticoid RU 486 raised progesterone plasma
concentration and delayed RLX peak release but did not
suppress it during treatment. This experiment provides
further evidence that relaxin and progesterone secretion
from aging corpora lutea of pigs are regulated through
separate mechanisms, and adrenal glucocorticoids may be
involved in such a regulation process.
Introduction
Relaxin (RLX), a peptide hormone with partial
structural homology to insulin, and progesterone are
produced by corpora lutea of pigs during pregnancy and
after hysterectomy. Although the normal duration of the
estrous cycle is about 21 days in the pig, the corpora lutea
secrete progesterone and small amounts of RLX. During a
normal pregnancy of 114 days, circulating progesterone
concentrations peak by day 8 and remain high ( » 25 ng ml-1)
until they decrease just before parturition. Relaxin
accumulates in electron dense granules of luteal tissue and
increases gradually during pregnancy, and it is released into
the blood in peak amounts just before parturition. After
hysterectomy of unmated gilts, the corpora lutea are
maintained to day 150; these aging corpora lutea continue to
secrete RLX and progesterone. Profiles of decreased
secretion and simultaneous peak release of RLX from these
aging corpora lutea at day 113 were similar to those on the
same day just preceding normal parturition. The RU 486
(11§-[4-dimethylamino phenyl] 17§-hydroxy 17 a -[1-
propy]estra-4,9-dien-3-one) acts with high affinity as an
antagonist for progesterone receptor; RU 486 also has
antiglucocorticoid activity. Oral administration of RU 486
to late-pregnant gilts induces parturition within 34 hours
compared with 82 hours in placebo treated controls.
Progesterone decreased abruptly to basal levels during the 2
days that RU 486 was given compared with the controls.
The RU 486 elevated circulating prolactin (PRL)
concentrations in hysterectomized gilts with aging corpora
lutea, and PRL maintained luteal function throughout a 10-
day period in hypophysectomized-hysterectomized pigs.
These results provide strong evidence that the antagonist
effect of RU 486 on progesterone/ glucocorticoid receptor
results in an abrupt increase in PRL secretion in
hysterectomized gilts with aging corpora lutea. In contrast
with hysterectomized animals, the acute luteolytic effects of
RU 486 depend on the presence of the uterus or conceptuses
in the pig. The objective of this study was to determine
whether glucocorticoids directly affect RLX and
progesterone secretion by aging corpora lutea in
hysterectomized gilts.
Materials and Methods
Animals. Purebred Yorkshire gilts (8 months old; » 125 kg
body weight) that had exhibited at least one normal estrous
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cycle (18Ð23 days; estrus = day 0) were used in this
experiment. Unmated gilts were hysterectomized on days
6Ð8 of the estrous cycle. The number of corpora lutea and
diameter of each were recorded. Four randomly selected
corpora lutea were marked on each ovary with a loop of
black silk suture for later identification. Reexamination of
the state of the ovarian structures was performed at the end
of the experiment through midventral laparotomy.
Experimental groups. On day 98, two days before the start
of blood collection, gilts were anesthetized and
catheterization (i.d., 1.27 mm; o.d., 2.29 mm; Tygon¨
microbore tubing, Fisher Scientific, Pittsburgh, PA) of the
cranial vena cava was performed to allow for repeat blood
sampling. The catheter was tunneled under the skin and
exteriorized at the junction of the scapulae. Blood samples
were collected via the cranial vena cava beginning on day
100 to 124. Sequential samples were collected (0800 and
2000 hours) from day 100 to 124. Blood samples were
immediately centrifuged (2,000 X g, 4° C, 10 minutes).
Plasma was stored at Ð20° C for radioimmunoassay of RLX
and progesterone. Dexamethasone (total of 30 mg day-1)
was injected intramuscularly at 0800 and 1600 hours from
days 110Ð118 (n=5); control animals received vehicle
injection twice daily during this period (n=6). The RU 486
(4 mg kg-1 body weight) was administered orally once a
day from days 111Ð115 (n=7). The RU 486 was mixed with
a small amount of feed and given to the pigs at 0800 hours.
All feed mixed with RU 486 was consumed by the pigs
within 20 minutes; placebo-treated controls were given the
same amount of feed without the drug at this time (n=6).
Radioimmunoassays (RIA). The RLX concentrations were
quantified in duplicate in aliquots of 100 and 200 m l of
plasma with a double antibody RIA by using [125I]
monotyrosylated porcine RLX and R6 antibody from B. G.
Steinetz by procedures we described previously. The assay
sensitivity was 40-pg tube-1. The inter- and intra-assay
coefficient of variance (mean – SE) were 12.4% (n=3 assays
sample-1) and 6.2% (n=5 samples), respectively;
nonspecific binding was 2.8%.
Plasma progesterone was extracted with a benzene-
hexane mixture (1:2 vol/vol). Plasma samples (100 m l) were
extracted in duplicate. Plasma extracts were assayed for
progesterone by using the fully characterized antibody
(GDN antiprogesterone-11-BSA 337). Recovery after
extraction with benzene-hexane was 89%, and the
sensitivity of the progesterone RIA was 50 pg tube-1. The
inter- and intra-assay coefficient of variance was 13.3%
(n=5 assays sample-1) and 9.8% (n=6 samples),
respectively; nonspecific binding was 3.2%.
Statistical analyses. Experimental units were the individual
pigs, which were assigned to treatments at random. Data
were analyzed by split-plot analysis of variance. A one-way
analysis of variance and a Student's t-test for continuous
variables was used for comparisons between treatment
groups.
Results and Discussion
Effects of dexamethasone and RU 486 on progesterone
concentrations in peripheral plasma. Progesterone plasma
concentrations in the placebo-treated gilts decreased
abruptly at days 111Ð113 but were maintained at 18Ð20 ng
ml-1 to day 124 (Figure 1A). Progesterone plasma
concentrations (14– 2.5 ng ml-1) were unaffected by twice
daily injection of dexamethasone for 8 days compared with
the vehicle-treated controls (15– 2.0 ng ml-1; P>.82). In
contrast, progesterone concentrations in RU 486-treated
gilts were markedly increased (P<.01) during 5 days of
treatment compared with the decreasing hormone
concentrations in the hysterectomized controls (Figure 1B).
Following RU 486 treatment, progesterone concentrations
decreased but remained consistently greater than seen in
hysterectomized controls from days 116Ð124.
Effects of dexamethasone and RU 486 on relaxin
concentrations in peripheral plasma. In the placebo-treated
hysterectomized control groups, RLX plasma concentrations
increased steadily (5Ð8 ng ml-1) from days 100Ð110 (Figure
2A,B). A peak release of RLX (17 – 2.8 and 18 – 2.5 ng ml-1)
occurred at day 113 in the hysterectomized controls.
Thereafter, RLX remained significantly elevated (5Ð9 ng
ml-1) to day 124 in both control groups. In marked contrast,
dexamethasone treatment for 8 days consistently suppressed
(P<.01) RLX concentration (3 – .9 ng ml-1) compared with
peak RLX release in hysterectomized controls (Figure 2A).
Upon the withdrawal of dexamethasone at the end of the
treatment on day 118, RLX plasma concentrations began to
increase and peaked at 14– 2.1 ng ml-1 (P<.01) on day 120.
During 5 days of antiglucocorticosteroid treatment from
days 111Ð115 in the hysterectomized gilts, RLX peak
release was inhibited (P<.01) compared with the controls
(Figure 2B). Upon withdrawal of RU 486 treatment a
delayed RLX peak release (16– 1.9 ng ml-1) occurred on
day 117; however, the amplitude of this delayed RLX peak
did not differ from that in the controls (18 – 2.5 ng ml-1;
P>.20). Following the relaxin peak, the hormone
concentration remained elevated (6Ð7 ng
ml-1) to day 124 in both groups.
The main finding was that glucocorticoid
(dexamethasone) administration for several days in
hysterectomized gilts with aging corpora lutea markedly
suppressed peak relaxin release without affecting
progesterone secretion compared with vehicle treated
controls. It is well known that an inherent peak release of
relaxin occurs in unmated hysterectomized gilts at day 113
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that coincides with the prepartum peak relaxin release seen
at normal parturition (1). The programmed relaxin release
113 days after estrus does not depend upon hormonal
signals from the uterus or conceptuses in this species.
Although RLX secretion was suppressed during
dexamethasone treatment, it peaked soon after hormone
withdrawal. Furthermore, glucocorticoid treatment in these
hysterectomized gilts did not induce luteolysis as indicated
by sustained RLX and progesterone secretion to day 124.
Results from this experiment reveal that dexamethasone at
the given dose suppresses RLX secretion without causing
luteolysis and such suppression is reversible. In contrast, in
late-pregnant pigs and cattle, dexamethasone treatment
induces luteolysis and premature parturition.
The RU 486 acts with high affinity as an antagonist for
progesterone receptor and also has antiglucocorticoid
activity. In the mammalian uterus, progesterone binds with
its receptor to cause endometrial proliferation of epithelial,
glandular, mesenchymal, and vascular cells, and such
binding is required to maintain pregnancy to normal term.
The abortifacient actions of RU 486 in late pregnant pigs
may result from an interplay of prostaglandins,
glucocorticoids, and oxytocin on the maternal uterus and
cervix for expulsion of the conceptuses. An acute decrease
in circulating progesterone concentrations is a prerequisite
for parturition in this species, and RU 486 given during late
pregnancy abruptly decreases progesterone secretion and
induces parturition within 34 hours (2).
In the absence of the nongravid uterus, porcine corpora
lutea are maintained for prolonged periods by secreting
greater amounts of progesterone and lower concentrations of
estradiol-17§, estrone, and prolactin (PRL) compared with
pregnant animals. In sharp contrast with pregnant animals,
the progesterone/glucocorticoid antagonist RU 486
promotes both PRL and progesterone secretion and delays
peak RLX release in hysterectomized pigs. It is well known
that daily injection of purified pPRL in hypophysectomized-
hysterectomized pigs maintains progesterone secretion
throughout a 10-day period (3). Thus, the divergent effects
of the progesterone/glucocorticoid antagonist on
progesterone and RLX secretion by aging corpora lutea in
pregnant pigs may involve receptors in the uterus that
induce parturition with premature RLX release and luteal
demise, whereas in nongravid hysterectomized animals
receptors in hypothalamus-pituitary-ovarian (corpus luteum)
axis that delay RLX release and promote progesterone
secretion (2). The RU 486 binds to glucocorticoid receptors
and appears to at least partly stabilize the untransformed
8Ð9S glucocorticoid receptor in several systems.
Activators of protein kinase A unmask latent
transcription activating potential in the RU 486-
glucocorticoid receptor complex. In contrast, RU 486
promotes dissociation of the progesterone receptors from
heat shock proteins, receptor dimerization, and receptor-
DNA binding as effectively as the progestin agonist, R5020.
Thus, type I steroid antagonists are defined as ligands that
bind receptor but do not promote conversion of receptor to a
form capable of high affinity binding to DNA. Type II
steroid antagonists are defined as ligands that recapitulate
most of the early steps of agonist action, including
stimulation of DNA-binding activity of receptor. A
significant fraction of glucocorticoid receptor appears
activated and binds to DNA. Thus, RU 486 is classified as a
type II glucocorticoid antagonist.
In summary, these experiments provide evidence that
relaxin and progesterone secretion from aging corpora lutea
of pigs are regulated through separate mechanisms, and
adrenal glucocorticoids may be involved in this regulation
process not only during pregnancy but also in unmated
hysterectomized pigs.
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Figure 1. Progesterone concentration in peripheral plasma
(ng ml-1) in unmated, hysterectomized gilts (A) given i.m.
injection of dexamethasone (total of 30 mg day-1) at 0800
and 2000 hours (n=5) or vehicle injection (n=6) from days
110Ð118 and (B) oral administration of RU 486 (4 mg kg-1
body weight) at 0800 hours (n=7) or placebo-treated
controls given the same amount of feed at this time (n=6)
from days 111Ð115. Values are mean – SE.
Figure 2. Immunoreactive relaxin concentration in
peripheral plasma (ng ml-1) in unmated, hysterectomized
gilts (A) given i.m. injection of dexamethasone (total of 30
mg day-1) at 0800 and 2000 hours (n=5) or vehicle-
injection (n=6) from days 110Ð118; and (B) oral
administration of RU 486 (4 mg kg-1 body weight) at 0800
hours (n=7) or placebo-treated controls given the same
amount of feed at this time (n=6) from days 111Ð115.
Values are mean – SE.
